English | Español
Press release submission | Sep 27, 2018

ABBOTT CORPORATION: Receives CE Mark for First Troponin Test to Help Predict the Chance of Heart Attack in Apparently Healthy Adults Potentially Months to Years in Advance
Press release submission | Sep 23, 2018

ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Press release submission | Sep 23, 2018

ELI LILLY AND COMPANY: Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults
Press release submission | Sep 16, 2018

GENENTECH INC: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Press release submission | Sep 16, 2018

ASTRAZENECA: US FDA approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukemia

Press release submission | Sep 5, 2018

LIVONGO HEALTH: Becomes First Comprehensive Diabetes Offering to Add Abbott’s FreeStyle® Libre Pro System to Platform
Press release submission | Sep 5, 2018

NUVASIVE INC: To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

Press release submission | Aug 29, 2018

CETERIX ORTHOPAEDICS: Announces FDA Clearance of New Suture Cartridge, Providing Increased Flexibility and Enhanced Options for Surgeons

Trending
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court
+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'